Health Systems Research in a Complex and Rapidly Changing Context: Ethical Implications of Major Health Systems Change at Scale by MacGregor, Hayley & Bloom, Gerry
  






Title: Health Systems Research in a Complex and Rapidly Changing Context: Ethical 
Implications of Major Health Systems Change at Scale 
 
Citation: MacGregor, H., Bloom, G. (2016) Health Systems Research in a Complex and 
Rapidly Changing Context: Ethical Implications of Major Health Systems Change at Scale. 
Developing World Bioethics. (16) 3, pp. 158-167. 
 
Official URL: https://doi.org/10.1111/dewb.12115  
 
More details/abstract: This paper discusses health policy and systems research in complex 
and rapidly changing contexts. It focuses on ethical issues at stake for researchers working 
with government policy makers to provide evidence to inform major health systems change at 
scale, particularly when the dynamic nature of the context and ongoing challenges to the 
health system can result in unpredictable outcomes. We focus on situations where ‘country 
ownership’ of HSR is relatively well established and where there is significant involvement of 
local researchers and close ties and relationships with policy makers are often present. We 
frame our discussion around two country case studies with which we are familiar, namely 
China and South Africa and discuss the implications for conducting ‘embedded’ research. We 
suggest that reflexivity is an important concept for health system researchers who need to 
think carefully about positionality and their normative stance and to use such reflection to 
ensure that they can negotiate to retain autonomy, whilst also contributing evidence for health 
system change. A research process informed by the notion of reflexive practice and iterative 
learning will require a longitudinal review at key points in the research timeline. Such review 
should include the convening of a deliberative process and should involve a range of 
stakeholders, including those most likely to be affected by the intended and unintended 
consequences of change. 
 
Version: Published version. 
 
Terms of use:  © 2016 The Authors Developing World Bioethics Published by John Wiley & 
Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution 
License, which permits use, distribution and reproduction in any medium, provided the original 
work is properly cited. CC-BY. 
 
 
This is a download from OpenDocs at the Institute of Development Studies     
HEALTH SYSTEMS RESEARCH IN A COMPLEX AND RAPIDLY CHANGING
CONTEXT: ETHICAL IMPLICATIONS OF MAJOR HEALTH SYSTEMS
CHANGE AT SCALE









This paper discusses health policy and systems research in complex and
rapidly changing contexts. It focuses on ethical issues at stake for
researchers working with government policy makers to provide evidence
to inform major health systems change at scale, particularly when the
dynamic nature of the context and ongoing challenges to the health sys-
tem can result in unpredictable outcomes. We focus on situations where
‘country ownership’ of HSR is relatively well established and where there
is signiﬁcant involvement of local researchers and close ties and relation-
ships with policy makers are often present. We frame our discussion
around two country case studies with which we are familiar, namely China
and South Africa and discuss the implications for conducting ‘embedded’
research. We suggest that reﬂexivity is an important concept for health
system researchers who need to think carefully about positionality and
their normative stance and to use such reﬂection to ensure that they can
negotiate to retain autonomy, whilst also contributing evidence for health
system change. A research process informed by the notion of reﬂexive
practice and iterative learning will require a longitudinal review at key
points in the research timeline. Such review should include the convening
of a deliberative process and should involve a range of stakeholders,
including those most likely to be aﬀected by the intended and unintended
consequences of change.
INTRODUCTION
This paper discusses health systems and policy research in
complex and rapidly changing contexts and focuses on
ethical issues at stake for researchers working with govern-
ment policy makers to provide evidence to inform major
health systems change at scale.
There is a considerable body of literature on the ethics
of clinical research in low- and middle-income country
(LMIC) contexts, in particular the ethical issues associated
with large international clinical trials directed and funded
by external sources. Scholars have focused on areas such
as the implications of different socio-cultural and religious
settings for the extension of formalised procedures in the
ethics of clinical research to LMIC contexts, including the
need to take account of the multiplicity of views of what
constitutes ethical practice in different localities, and the
processes whereby ethical norms come to be constructed
in practice and in institutional settings.1 The inﬂuence of
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colonial histories and political economy in shaping how
people might respond to externally-driven medical interven-
tions has also received attention2 and the ethnography of
medical research is well established as a ﬁeld of study.3
Related scholarship has further underscored issues that arise
from doing clinical research in countries characterised by a
high burden of disease, health inequalities and poor health-
care provision.4 Detailed attention has been given to the
implications of such realities for ethics review boards
appraising clinical research proposed in LMIC, for example
considering whether the views of those recruited into
research will be elicited with respect to issues such as ade-
quate consent procedures, risks and beneﬁts of participation,
and the cessation of health-related services at the end of tri-
als.5 Suggestions to address these issues in research projects
have included the institution of community engagement
mechanisms such as community advisory boards6, or the
use of rapid ethnographic methods for assessing the views
of involved communities7, and mechanisms for sharing
research results.8 Hyder et al9 have also emphasised the
value of assessing the national and regional health system
functioning in deliberations on standards of care in clinical
trials.
An in depth review of the literature on international
clinical research is not the focus of this paper. However,
we recognise the relevance of insights regarding the nature
of social relations generated by health research and the
dynamics that can attend these engagements when inequal-
ities of power and resources exist.10 London11 argues that
the thorny nature of the issues at stake with clinical
research in LMICs has encouraged ethics boards to focus
largely on the implications of context for the procedural
elements of review, at the expense of considering the
broader ethical issues at stake that are connected to the
perpetuation of global health inequalities. He argues for a
Human Development approach to ethics of health research
in LMICs. This chimes with scholarship that explores the
principles for public health ethics in an era of global health
research.12 Pratt and Loff13 draw on political philosophy
to propose a justice framework to guide review of interna-
tional clinical research. The importance of the political
environment and the social and political structures and
levels of social accountability in setting health systems
norms and policy values has also been highlighted.14
More recently, attention has been drawn to the rise of
health policy and systems research (HPSR) as a ﬁeld and a
recognition that the nature of this kind of research, which
includes implementation research, brings a distinctive set
of ethical issues, speciﬁcally also in LMIC contexts15 and
in conﬂict settings with weak health systems and signiﬁ-
cant external intervention from donor agencies and
2 P.W. Geissler. ‘Kachinja are Coming!’ Encounters around a Medical
Research Project in a Kenya Village. Africa. 2005; 75:173-202; J. Fair-
head, M. Leach et al. Where Techno-Science Meets Poverty: Medical
Research and the Economy of Blood in The Gambia, West Africa. Soc Sci
Med 2006; 63: 1109-1120; P.W. Geissler and R. Pool. Popular Concerns
with Medical Research Projects in Africa – A Critical Voice in Debates
about Overseas Research Ethics. Trop Med Int Health 2006; 11: 975–982.
3 S. Molyneux & P.W. Geissler. Ethics and the Ethnography of Medical
Research in Africa. Soc Sci Med 2008; 67: 685-695.
4 S.R. Benatar. Reﬂections and Recommendations on Research Ethics in
Developing Countries. Soc Sci Med 2002; 54: 1131-1141; J. Azetsop.
New Directions in African Bioethics: Ways of Including Public Health
Concerns in the Bioethics Agenda. Dev World Bioeth 2011; 11:1 4-15; T.
Lahey. The Ethics of Clinical Research in Low- and Middle-Income Coun-
tries. Handb Clin Neurol 2013; 118: 301–313.
5 V. Marsh et al. Managing Misaligned Paternity Findings in Research
including Sickle Cell Disease Screening in Kenya: ‘Consulting Communi-
ties’ to Inform Policy. Soc Sci Med, 2013; 96: 192-199; S. Molyneux et al.
Conducting Health-Related Social Science Research in Low Income Set-
tings: Ethical Dilemmas Faced in Kenya and South Africa. J Int Dev
2009; 21: 309–326
6 M. Boga et al. Strengthening the Informed Consent Process in Interna-
tional Health Research through Community Engagement: The KEMRI-
Wellcome Trust Research Programme Experience. PLoS Med 2011; 8:9:
1-4; I. Jao et al. Involving Research Stakeholders in Developing Policy on
Sharing Public Health Research Data in Kenya: Views on Fair Process for
Informed Consent, Access Oversight, and Community Engagement. J
Empir Res Hum Res Ethics 2015; 10: 264-277; V. Marsh, op.cit. note 5.
7 A. Addissie et al. A Mixed-Methods Study on Perceptions Towards Use
of Rapid Ethical Assessment to Improve Informed Consent Processes for
Health Research in a Low-Income Setting. BMC Med Ethics 2014; 15:35:
2–12.
8 S. Bull et al. Best Practices for Ethical Sharing of Individual-Level
Health Research Data from Low-and Middle-income Settings. J Empir Res
Hum Res Ethics 2015; 10: 302–313.
9 A.A. Hyder & L. Dawson. Deﬁning Standard of Care in the Developing
World: the Intersection of International Research Ethics and Health Sys-
tems Analysis. Dev World Bioeth 2005; 5: 142–152
10 S. Molyneux, D. Kamuya & V. Marsh. Community Members
Employed on Research Projects Face Crucial, Often Under-Recognized,
Ethical Dilemmas. Am J Bioeth 2010; 10: 24-26; T. Chantler et al. Ethical
Challenges that Arise at the Community Interface of Health Research: Vil-
lage Reporters’ Experiences in Western Kenya. Dev World Bioeth 2013;
13: 30–37.
11 L. London. Ethical Oversight of Public Health Research: Can Rules
and IRBs Make a Difference in Developing Countries? Am J Public
Health 2002; 92: 1079–1084.
12 C. Chakraborti. Systemic Negligence: Why it is Morally Important for
Developing World Bioethics. Dev World Bioeth 25 April 2014; 1-6; S. R.
Benatar, P.A. Singer & A.S. Daar. Global Challenges: The Need for an
Expanded Discourse on Bioethics. PLoS Med 2005; 2:7; C.B. IJssel-
muiden et al. Evolving Values in Ethics and Global Health Research. Glob
Public Health 2010; 5: 154–163.
13 B. Pratt & B. Loff. A Framework to Link International Clinical
Research to the Promotion of Justice in Global Health. Bioethics 2014; 28:
387–396.
14 A.A. Hyder et al. Integrating Ethics, Health Policy and Health Systems
in Low- and Middle-Income Countries: Case Studies from Malaysia and
Pakistan. Bull World Health Organ 2008; 86: 606-611; G.M.A Hussein.
Democracy: the Forgotten Challenge for Bioethics in the Developing
Countries. BMC Med Ethics 2009; 10:3 1–4.
15 A.A. Hyder et al. (a) The Ethics of Health Systems Research in Low-
and Middle-Income Countries: A Call to Action. Glob Public Health
2014; 9: 1008-1022; A.A. Hyder et al. (b) Ethical Review of Health Sys-
tems Research in Low- and Middle-Income Countries: A Conceptual
Exploration. Am J Public Health 2014; 14:28–37.
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researchers that introduce signiﬁcant power dynamics.16
Krubiner and Hyder17 review the differences between HSR
and clinical research and outline some of the ethical princi-
ples to consider, with a recognition also of the importance
of drawing on scholarship in other ﬁelds. The concern with
external intervention in national contexts has brought to
the fore suggestions for the importance of ‘partnership’ as
an ethical model.18 Pratt and Hyder19 use the principle of
justice as a lens to unpack the issue of ‘responsiveness’
for HSR in the light of externally driven research. They
identify responsiveness to country priorities and country
needs as an important principle and suggest in conclusion
that consultation with key stakeholders in national govern-
ments and attention to ensuring ‘country ownership’ is a
key to ethical HSR. They suggest this ‘embeddedness’ as
a way to begin to address the power dynamics of health
research in LMICs.
It is this suggestion of ‘embeddedness’ as an important
principle that we wish to take as our departure point in this
paper. In particular, we focus on situations where ‘country
ownership’ of HPSR is relatively well established. Some
of this research might still have external funding sources,
but we are interested here in situations where there is sig-
niﬁcant involvement of local researchers and usually close
ties with policy makers, or indeed even a blurring of
boundaries in professional afﬁliations. The focus is less on
external power relations with funders and outside research-
ers but on internal relations between different kinds of
stakeholders, such as between government ofﬁcials and
researchers. We frame our discussion around two country
case studies with which we are familiar, namely China and
South Africa. Whilst there are many differences, these
countries both have a well-established national research
community and research councils, and are confronting sig-
niﬁcant health service delivery challenges. This situation
puts pressure on researchers to provide evidence to inform
rapid health systems change and improve access to ser-
vices. We argue also that it is signiﬁcant that in both these
countries there is a degree of entitlement to heath care
from the state. Indeed in South Africa, health has been
made a constitutional right.
We begin with discussion of the nature of the research
environment in such contexts and the kinds of demands
this places on health system researchers to generate evi-
dence to inform change. Our key concern is to consider
how health system researchers can produce knowledge of
relevance to policy makers in an ethical way. We do not
focus on current review procedures in these settings.
Rather, we draw out the implications for doing research in
such environments in terms of negotiating the political nat-
ure of health system priority-setting and the different moral
framings of health problems and responses. We underscore
the complex relationships between researchers and govern-
ment decision-makers. We then discuss the ethical chal-
lenges that arise for researchers given this imperative to be
responsive to health system priorities, especially with
respect to negotiating positionality and autonomy. The
efforts of researchers in such situations are closely linked
to broader national development agendas and aspirations,
including addressing persistent societal inequalities. Our
perspective on these issues is drawn from our location in
development studies. We suggest that the concept of
reﬂexivity and the ability to think carefully about one’s
positionality is important for health system researchers
who need to consider how to retain autonomy in research,
whilst contributing evidence for health system change. A
research process informed by the notion of reﬂexive prac-
tice and iterative learning will require a longitudinal
review at key points in the research timeline. Such review
should include the convening of a deliberative process and
should involve a range of stakeholders, including those
most likely to be affected by the intended and unintended
consequences of change.
COMPLEX AND RAPIDLY CHANGING
CONTEXTS: UNDERSTANDING THE
HEALTH SYSTEM AND THE RESEARCH
ENVIRONMENT
This section describes the research environment that health
system researchers face in countries that are experiencing
rapid and interconnected changes and where the institu-
tional arrangements within which the health sector is
embedded remain relatively weak20. These researchers can
be viewed as actors, who play a speciﬁc role within their
health system. We then use the examples of China and
South Africa to illustrate the nature of the research envi-
ronment in such contexts and the implications for the
research process and the role of researchers.
The research environment
The macroeconomic context in the countries referred to
above is of an increasing reliance on markets, which are
16 P. Hill. Ethics and Health Systems Research in ‘Post’–Conﬂict Situa-
tions. Dev World Bioeth 2004; 4: 139–153.
17 C.B. Krubiner & A.A. Hyder. A Bioethical Framework for Health Sys-
tems Activity: A Conceptual Exploration Applying ‘Systems Thinking’
Health Systems 2014; 3:124–135
18 D.W. Dowdy. Partnership as an Ethical Model for Medical Research in
Developing Countries: the Example of the ‘Implementation Trial’. J Med
Ethics 2006; 32: 357–360.
19 B. Pratt & A.A. Hyder. Reinterpreting Responsiveness for Health Sys-
tems Research in Low and Middle-Income Countries. Bioethics 2015; 29:
379–388.
20 D. Leonard et al. Institutional Solutions to the Asymmetric Information
Problem in Health and Development Services for the Poor. World Dev
2013; 48: 71–87.
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becoming integrated into the global economy, and of rapid
urbanisation. This has led to changing patterns of inequal-
ity and social exclusion. Population ageing and several fac-
tors that increase the risk of chronic non-communicable
diseases, as well as chronic illness from HIV infection, has
led to big changes in the pattern of ill health. New tech-
nologies are opening up opportunities for managing illness
and also bringing new challenges. Ecological changes,
such as intensiﬁcation of animal husbandry, exposure to
environmental pollutants and climate change, are introduc-
ing populations to new health risks. Health systems previ-
ously designed to meet the needs of a poor and largely
rural population at low cost and using very basic technol-
ogy need to change substantially to meet these challenges.
Many countries have pluralistic health systems with a
variety of providers in terms of their training, their rela-
tionship to government and markets and the degree to
which they are regulated. The poor tend to obtain a large
proportion of medical advice, services and drugs from
health service providers and drug sellers working outside
the regulatory framework. Actors within these systems
respond to a number of factors, in addition to government
policy. These include ﬁnancial incentives, reputation and
widely accepted behavioural norms. Meanwhile, almost
universal coverage by the mass media and growing use of
mobile phones and social media mean that the population
has access to many sources of information and inﬂuencing
messages beyond those authorised by the state. In many
countries, political systems have emerged with competitive
elections and the growing inﬂuence of a variety of civil
society groups. Some health system analysts have likened
health sectors with a large number of actors responding to
a variety of inﬂuences to a complex adaptive system, in
which the response to an intervention is strongly affected
by the relationships between actors and a variety of known
and unknown inﬂuences21 and power relations.22
Another way to understand this situation is through the
lens of historical institutionalism, which emphasises the role
of institutions, and the formal and informal rules that under-
pin them, for the effective performance of a system.23 These
rules include ‘ethical’ norms of behaviour, which make an
individual’s response to a situation more predictable. One
of the major challenges of managing health system develop-
ment is to build these institutions and construct these
norms, including with respect to expectations of the beha-
viour of health professionals and the nature of care.
The research to generate evidence that can inform
change and assist policy-makers in these complex contexts
is likely to be characterised by several features – such as
close relationships between research and policy-makers
and even blurring of positions - that are determined by this
more complex and unpredictable research environment.
We will return to these in the discussion in section 2.4.
The following examples from China and South Africa
illustrate this environment and the kind of demands that
policy-makers responsible for managing health system
change make on researchers.
China
Over the past three decades, the Chinese health system has
had to adapt to a number of inter-related economic, social
and demographic changes associated with that country’s
transition from a command economy to a socialist market
economy.24 The health sector has implemented a sequence
of reforms to the organisation, management and ﬁnance of
health services and it is still evolving new norms of beha-
viour to guide relationships between clients, health workers
and other health system actors. This has taken place in
response to problems, as they have emerged. The outcome
of any one intervention has been unpredictable and it has
been impossible to predict the ultimate shape of the health
system. Health system managers and policy-makers have
been under constant pressure to manage a process of
change; business as usual has not been an option. They
have sought strategies to adapt to changing circumstances,
whilst minimising the risk of deleterious outcomes.
The government’s approach towards managing eco-
nomic and social change has been to deﬁne broad develop-
ment objectives and encourage local governments to test
new approaches for achieving them.25 When policy-makers
have anticipated the need to address a new problem or
launch a new intervention, they have encouraged a few
localities to experiment with new approaches ﬁrst. They
have used lessons from these experiments to inform
national strategies. Over time, specialised research insti-
tutes (universities and government think tanks) have
played a growing role. The management of health sector
change has followed this pattern and has involved a grow-
ing number of researchers.
During the initial phase of China’s economic reforms
starting in the late 1970s the major emphasis of national
policy was on encouraging economic growth, managing
the transition from a command to a market economy and
avoiding social disorder. Chinese government revenue fell21 D. Peters. The Application of Systems Thinking in Health: Why use
Systems Thinking? Health Res Policy Syst 2014; 12(1).
22 L. Gilson et al. Advancing the Application of Systems Thinking in
Health: South African Examples of a Leadership of Sensemaking for Pri-
mary Health Care. Health Res Policy Sys 2014; 12 (1).
23 P. Pierson & T. Skocpol. 2002. Historical Institutionalism in Contem-
porary Political Science. In I. Katznelson & H. Milner eds Political
science: The State of the Discipline 693–721 New York: Norton.
24 G. Bloom. Building Institutions for an Effective Health System: Les-
sons from China’s Experience with Rural Health Reform. Soc Sci Med
2011; 72: 1302–1309.
25 L. Husain. Logics of Government Innovation and Reform Management
in China. STEPS Working Paper No. 85. Brighton: STEPS Centre 2015.
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substantially during the initial phases of transition and
government subsidies to public health facilities did not
keep up with rising prices. These facilities had to rely on
charges to patients to remain ﬁnancially viable.26 At the
same time, a large proportion of health workers in rural
facilities lacked sufﬁcient training as a result of human
resource policies during the 1970s, which downplayed the
importance of specialised technical qualiﬁcations. This
affected the quality of services. During that time, the gov-
ernment priority for its health facilities was similar to that
of other sectors: to prevent bankruptcy and mass layoffs of
personnel, whilst encouraging these facilities to generate
revenue from the provision of services. These objectives
were largely achieved, but a number of problems emerged
in terms of a rapid rise in health care costs and growing
barriers to access to care by the poor.27
Zhang et al28 report on the role of research during the
1990s in bringing to the attention of policy-makers the
growing problems with the rural health services. Many
journal articles and reports documented the rising cost of
medical care and the impact on access to services by poor
rural residents. The media began to report these ﬁndings.
In 2005 a major report by the Development Research Cen-
tre of the State Council, a high level government think
tank, summarised these ﬁnding. This report highlighted
shortcomings in the health system and opened a policy
debate, which eventually led to a big health sector reform
in 2009. Research institutes were also instrumental in the
design of experimental rural health insurance schemes
aimed at reducing the ﬁnancial barriers to care. These
schemes were undertaken in partnership with county gov-
ernments. They tended to cover large numbers of people
and affected many health sector employees. The research-
ers who undertook these activities were mostly based in
universities or government think tanks. They tended to be
funded by the Ministry of Health and a number of senior
researchers served on government advisory committees. In
that position they acted as advocates for increased govern-
ment funding of rural health services, on behalf of the
Ministry of Health.
During the early 2000s there was a substantial change
in government policy in favour of ensuring greater inclu-
sion of all population groups. The large body of research
and experimentation meant that the Ministry of Health was
well placed to advocate for a national rural health insur-
ance scheme, which was launched in 2003. These schemes
have received increasing levels of ﬁnance since the launch
of a major health reform in 2009. There is now a large
and growing body of research on the emerging problems
within these schemes and on possible strategies for further
reform.29
The major inﬂuences on the design and implementation
of local experimental interventions and national strategies
are largely political. The change in government policy,
described above, was instrumental in the decision to com-
mit government funds to rural health insurance. However,
the large body of evidence on the problems with the health
system and the demonstration of the feasibility of rural
health insurance in the small-scale experiments meant that
the Ministry of Health could act quickly when overall
development priorities changed.
This history demonstrates the growing importance of
researchers to China’s health policy process. Their choice
of subjects for investigation and of policy interventions to
test can materially affect the direction of health system
development. This makes the normative stance they take
and the degree to which they seek the perspectives of dif-
ferent stakeholders, including the poor, important. It high-
lights the need for more thought about the beneﬁts and
risks associated with partnerships with local governments
to undertake experimental interventions. It also gives
importance to the capacity of researchers to design and
undertake studies appropriate to a complex context. The
training of Chinese researchers has tended to focus on
building certain technical skills. For example, China has
an active network aimed at strengthening national capacity
for health economics research. Chinese centres of health
system research are at an early stage in creating mecha-
nisms for ethical review of their work that takes into
account their role as signiﬁcant partners in change manage-
ment processes.
South Africa
In South Africa, the research environment is similarly
complex and politically inﬂuenced, which gives rise to sit-
uations for health systems researchers that generate ethical
questions that do not have straightforward responses. An
interesting case to unpack relates to the high HIV preva-
lence in the country, an example which illustrates the
implications of contested framings of a problem and priori-
ties for research and policy responses. Unfortunate timing
meant that the HIV epidemic in South Africa came to the
fore at the same time as the country was facing a politi-
cally demanding democratic transition in the 1990s. The
26 Yip, W. and Hsiao, W. 2015. What Drove the Cycles of Chinese Health
System Reforms?, Health Systems and Reform 1:1, 52-61.
27 G. Bloom. Building Institutions for an Effective Health System: Les-
sons from China’s Experience with Rural Health Reform. Soc Sci Med
2011; 72: 1302-1309; W. Yip & W. Hsiao. What Drove the Cycles of Chi-
nese Health System Reforms? Health Systems and Reform 2015; 1: 52-61;
Duckett, J. 2011 The Chinese State’s Retreat from Health: Policy and the
Politics of Retrenchment Oxford: Routledge.
28 Z. Zhang, L. Fang & G. Bloom. 2010. The Rural Health Protection
System in China in Health Policy in Transition: The Challenges for China
V. Lin et al. eds Peking University Medical Press.
29 X. Liang et al. The Effect of New Cooperative Medical Scheme on
Health Outcomes and Alleviating Catastrophic Health Expenditure in
China: A Systematic Review. PLoS ONE 2012; 7(8) e40850.
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second elected president of the democratic South Africa,
Thabo Mbeki, notoriously denied the connection between
the supposed immunodeﬁciency syndrome and a speciﬁed
virus, citing poverty as the predominant cause of the evi-
dent ill health of a large number of people. In his analysis
of the situation, he aligned himself with dissident AIDS
scientists, and pointed to a colonial legacy of racism which
in his view also biased scientists to conclude that Africans
were responsible for the human emergence and spread of
diseases such as HIV. The then minister of health sub-
scribed to the same views and refused to invest in a
national ART treatment programme, preferring to promote
‘indigenous’ remedies such as African potato and the vita-
mins sold by the AIDS dissident Matthias Rath.30 Some
members of the public health establishment at the time
also expressed concerns about whether the state could sup-
port the cost of a national HIV treatment programme. Fur-
thermore, doubts surfaced as to whether those most
affected in very socio-economically deprived areas would
adhere to long term medication. However, in 2001 the
NGO Medecins Sans Frontieres (MSF) started providing
independent HIV treatment in the socio-economically
deprived area of Khayelitsha on humanitarian grounds, and
supported research at the site focused on the realities of
provision in such environments. Activists and biomedical
researchers formed alliances to promote advocacy for uni-
versal treatment in South Africa, adopting a position
framed in terms of the constitutional right to health and
the moral responsibility of the state to act. A research
agenda was driven forward on issues such as the long term
cost effectiveness in public health terms of treating to pre-
vent progression to AIDS. By 2003 the state had bowed to
pressure from activists to establish a free treatment pro-
gramme. In 2004 the early results of research in the MSF
clinic in Khayelitsha suggested better adherence rates than
had been anticipated and later research also showed
remarkable outcomes for seriously ill people, who had
been placed on treatment.31
This period of deﬁning reaction to the HIV epidemic in
the late 1990s and early 2000s in South Africa illustrates a
situation where contestation existed as to the moral fram-
ing of the health crisis and its aetiology, and therefore of
the best response and policy solutions. It also illustrates
the complex alliances and blurred boundaries that existed
between advocacy, public health and health systems
research, and government policy-making. In the early
2000s some researchers felt opposed to the government’s
ideological position on HIV and would not accept the gov-
ernment’s lead on priorities. The blurred boundary between
political activism and health research had already existed
as part of the resistance to the Apartheid state’s policies
prior to the democratic transition of 1994, and a recent his-
torical precedent thus existed of not trusting the govern-
ment’s health care ideologies or priority-setting and of
researchers actively promoting alternative agendas. It was
clear that no one ‘truth’ prevailed in the late 1990s as to
how to perceive the ethical issues at stake in the context
of the HIV epidemic. Different framings included Mbeki’s
assertion of a racist conspiracy, whilst researchers and acti-
vists framed the lack of government intervention and treat-
ment provision in moral terms, with the Treatment Action
Campaign even accusing the Minister of Health, Shabal-
ala-Msimang, of homicide. The Treatment Action
campaign was also condemnatory of the ethics of large
multi-national drug companies and the cost of life-saving
anti-retroviral therapy. Clinical research also came under
increasing ethical scrutiny as certain trials were accused of
using African participants as ‘guinea pigs’, promoting
externally driven agendas and not sharing the beneﬁts of
research equally with African populations.32
As the government position on HIV gradually shifted in
the 2000s, greater convergence of opinion occurred on pri-
orities for response, with increasing attention to emerging
research on how best to respond to HIV in endemic set-
tings characterised by poor populations, and a health sys-
tem already under pressure. A new Minister of Health in
2008 signiﬁcantly opened up alliances with civil society,
and when Aaron Motsoaledi took up the position in 2009,
he instituted campaigns for HIV testing and shaped poli-
cies around international evidence for expanding treatment
as prevention. In some instances, public health researchers
and erstwhile activists have shifted into government policy
positions or work closely with government so that this
blurring of boundaries has continued. Departments of
Health at provincial and national levels look to health sys-
tems researchers to give warning of emergent problems as
South Africa has been establishing one of the most exten-
sive public ART treatment programmes globally. The sig-
niﬁcant successes of recent years have been demonstrated
in research ﬁndings, such as levels of HIV mortality equiv-
alent to comparable populations in the US.33 However,
concern has also arisen regarding falls in percentages of
30 S. Robins & B. von Lieres. Remaking Citizenship, Unmaking
Marginalization: The Treatment Action Campaign in Post-Apartheid South
Africa Can J Afr Stud 2004; 38:575-586; D. Fassin & H. Schneider. The
Politics of AIDS in South Africa: Beyond the Controversies. BMJ, 2013;
326:495-7; D. Fassin. 2007. When Bodies Remember: Experiences and
Politics of AIDS in South Africa, Los Angeles: University of California
Press; N. Nattrass. 2007. Mortal Combat: AIDS Denialism and the Strug-
gle for Antiretrovirals in South Africa, Durban: University of Kwa-Zulu
Natal Press; N. Geffen. Echoes of Lysenko: State-Sponsored Pseudo-
Science in South Africa. Soc Dyn 2005; 31: 182–210.
31 D. Coetzee et al. (2004). Promoting adherence to antiretroviral therapy.
AIDS, 18 (Supplement 3) S27-S31; A. Boulle, et al. Seven-Year Experi-
ence of a Primary Care Antiretroviral Treatment Programme in Khayelit-
sha, South Africa. AIDS 2010; 24: 563–572.
32 Lahey, op. cit. note 4.
33 A. Boulle et al. Mortality in Patients with HIV-1 Infection Starting
Antiretroviral Therapy in South Africa, Europe, or North America: A Col-
laborative Analysis of Prospective Studies. PLoS Med 2014; 11: 1001718.
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HIV positive patients retained in care.34 This has led pol-
icy makers to explore new models of care to promote
adherence in treatment programmes, including paying
attention to experimentation with ART clubs and commu-
nity based health workers by NGOs.35 The problem of co-
infection with drug resistant TB has been highlighted as
MSF continues to experiment and share ﬁndings for forms
of community-based treatment. Researchers who feel
strongly that certain groups have less access to HIV ser-
vices or face rights violations, have framed research
around giving voice to constituencies of patients as mar-
ginalised, such as HIV positive women, or LGBT commu-
nities.36 Gender activists engaged in public health research
have similarly highlighted their view that integration of
Sexual and Reproductive Health with HIV services
requires more attention.37
With increasing recognition of a burden of non-commu-
nicable disease in the South Africa, attention has shifted to
the lessons that can be learned from experience with HIV
programmes in order to make health systems more able to
provide care and support for all chronic lifelong condi-
tions. Some frame this in terms of justice and ensuring
equity by extending similar levels of care and sharing con-
siderable donor and state resources that have been invested
in HIV over the past decade. Given resource limitations
and some resistance from dedicated HIV specialists to
reducing budgets for HIV or harmonising care for chronic
lifelong conditions, and concerns about the possible unin-
tended consequences on HIV indicators, the political nat-
ure of framings and responses is again very evident as
‘integration’ becomes a disputed policy idea. In the current
political environment, health systems researchers are
indeed expected by government policy makers to provide
evidence for action on issues perceived to be the pressing
priorities. Gilson and McIntyre38 have begun important
analysis of some of the gains and practical challenges of
working at this interface for health system researchers in
South Africa.
Ethical challenges for research in complex and
dynamic contexts
The examples of China and South Africa highlight how
the roles of their health system researchers differ in
important respects from those undertaking clinical trials
and other medical experiments. Whilst we have not stud-
ied ethics committees in the countries, we have drawn in
the examples on general observations from our experi-
ence. In this section we discuss some features of
research that we see as important in order to appreciate
the ethical tensions and the challenges for HPSR in such
complex and dynamic settings. We have focused on
researchers involved in HPSR in close relationship with
national policy makers and our observation is that this
kind of relationship is increasingly important and needs
to be taken into account. Our case examples illustrate
how researchers are involved in experimental interven-
tions, which can rapidly lead to the implementation of
reforms at scale.
Krubiner and Hyder39 propose a framework for under-
standing the ethical issues of HSR that incorporates ‘sys-
tems thinking’. This involves an understanding of the
way in which such research can catalyse change at the
level of the health system and have consequences and
impact on an extensive scale. Similarly, in the complex
research environments that we have discussed, the inter-
ventions associated with HPSR are much less circum-
scribed and controlled than the archetypal study for
which medical ethics has evolved and uncertainty is
inevitable. Often, whole populations and communities are
affected as opposed to individual participants in a drug
trial. It would be a challenge to ensure that all those
potentially affected by the intervention could agree to it,
or to ensure that individuals could withdraw. In many
cases, the timeframe of the intervention can be long and
involve signiﬁcant engagement with a particular commu-
nity and locality over a long period. It is difﬁcult to dif-
ferentiate between the ethical considerations of the initial
experimental interventions and those concerning policy
reform.
Issues of unequal power relationships are important and
are expressed through disputed framings of the problems
to be addressed as well as the appropriate interventions. If
the viewpoints of the poor and socially excluded are not
taken into account, the interventions are unlikely to meet
their needs. Institutions are often frail, making both the
short and long-term impact of an intervention unpre-
dictable. One characteristic of this kind of complex reality
34 M. Osler et al. A Three-Tier Framework for Monitoring Antiretroviral
Therapy in High HIV Burden Settings. J Int AIDS Soc 2014; 17(1).
35 M. Luque-Fernandez et al. Effectiveness of Patient Adherence Groups
as a Model of Care for Stable Patients on Antiretroviral Therapy in
Khayelitsha, Cape Town, South Africa. PLoS ONE 2013; 8:56088; G.
Fatti et al. Improved Survival and Antiretroviral Treatment Outcomes in
Adults Receiving Community-Based Adherence Support: 5-Year Results
From a Multicentre Cohort Study in South Africa. J Acquir Immune Deﬁc
Syndr, 2012; 61:50-58.
36 A. Muller & H. MacGregor. Sexual and Reproductive Health Rights of
Women Living with HIV in South Africa IDS Evidence Report 3
Brighton: Institute of Development Studies March 2013.
37 J. Kehler et al. 2010. Where are the Human Rights for Pregnant
Women? Scale-Up of Provider-Initiated HIV Testing of Pregnant Women:
The South African experience Cape Town: AIDS Legal Network; S.
Cooper & J. Harries, 2009. If I Could Properly Understand and get the
Right Information: A Qualitative Study on the Sexual and Reproductive
Health Needs and Rights of HIV-Positive Women, CSSR Working Paper
Series, 256.
38 L. Gilson & D. McIntyre. The Interface Between Research and Policy:
Experience from South Africa. Soc Sci Med 2008; 67: 748–759. 39 Krubiner & Hyder, op.cit note 17.
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is that there is a great deal of uncertainty about the out-
come of an intervention.
In this context, where government ofﬁcials are imple-
menting complex change processes, the boundary between
a researcher, a government ofﬁcial and a member of an
organisation advocating major reforms can be blurred so
that the view of the researcher and her study as outside the
health system is not tenable. This makes role boundaries
harder to deﬁne as the researcher becomes a player in a
complex environment. Perturbing the environment is likely
to have consequences, some of which are unintended. The
researcher operates in a reality where agency is diffused
and policy processes are political and contested.
In this reality, the work of the typical ethical review
board is unlikely to address all the ethical challenges that
researchers engaged in health system change processes
face. The following section outlines concepts that we see
as important for underpinning ethical research and for con-
sidering how to adapt and support ethical review in these
contexts.
IMPLICATIONS FOR THE ETHICAL
CONDUCT AND REVIEW OF HEALTH
SYSTEMS RESEARCH IN SUCH
SETTINGS
In South Africa and China, researchers have well-estab-
lished roles in helping the health system adapt to rapidly
changing realities. In both countries they have privileged
access to information and their outputs are perceived as
having legitimacy and reﬂecting aspects of the real situa-
tion. This legitimacy derives from the reputation of univer-
sities as centres of scientiﬁc excellence and also from the
use to which research ﬁndings have been put. In South
Africa this legitimacy derives, in part, from the role of
researchers in documenting major health system problems
during the Apartheid period and in China it reﬂects the
growing use of research ﬁndings by government ofﬁcials
in policy debates. In both countries, the researchers have
some autonomy in deﬁning research topics and in produc-
ing and publishing ﬁndings. This autonomy is underpinned
by a level of security of employment. Their decisions can
inﬂuence policy debates. This raises questions about how
they should use this power ethically. We propose some
responses to these questions below.
Make normative position clear and encourage
reﬂexivity
In the selection of research topics and in drawing infer-
ences from the ﬁndings it is important to make the norma-
tive position of the researcher clear and to encourage
researchers to reﬂect on the implications of their positions
and roles for the research. In both South Africa and China
the government has stated a commitment to the provision
of universal access to high priority health services. In both
cases, the research discussed took this as an overall objec-
tive. Whilst responsiveness to national research priorities is
an important principle, the position of researchers might
not always align with some or all government policy-
makers. We suggest that it is important to convene dia-
logue with policy-makers and other stakeholders during
research proposal development and that this dialogue
should include discussion of normative positions. This will
require reﬂection on the part of researchers as to their posi-
tionality in order to negotiate and retain autonomy. One
strategy could be to accept the blurred boundaries between
researchers and policy-makers if these are present, as well
as the positioning of researchers as partly on the ‘inside’.
An aspect of the research might include monitoring of
change due to an intervention and explicit analysis of the
effects of such change and the implications. It might be
appropriate to conceptualise the role of the health system
researchers as being part of a process of change, whilst
also evaluating change and observing for unintended con-
sequences. Such a positioning of researchers as engaged in
‘learning by doing’ in the research process, rather than tak-
ing up the role of examining as outside observers, would
mark a clear departure. An ability on the part of research-
ers to be reﬂexive will also increase awareness of the situ-
ations where it might be necessary to negotiate with policy
makers to ensure independence in the research focus and
analysis in order to retain autonomy. An ongoing regular
dialogue with policy-makers throughout the duration of
research and attention to those relationships and clear
channels of communication might well make such negotia-
tion easier.
If we take the normative position that policy should
beneﬁt the poor and socially excluded, it will be important
to assess intended and unintended consequences of a pol-
icy initiative for them. In a complex context, it is impossi-
ble to predict the outcome of an intervention and it is
important to assess multiple points of view. It is especially
important to take into account the perspectives of the poor
and less powerful.
Deﬁne the kind of evidence necessary to inform
decision-making
The design of health systems research needs to take into
account the context and the likely responses of the differ-
ent actors.40 It should also take into account the need for
systematic information on the functioning and organisation
of the system before the implementation of an intervention
at scale. The ability to undertake this kind of scoping work
40 G. Bloom & S. Wolcott. 2012. Building Institutions for Health and
Health Systems in Contexts of rapid change. Soc Sci & Med; 2012.
96:216-222.
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is a core skill for those engaged in HSR. One aspect of
ethical review is to ensure that an intervention is based on
this kind of analysis. The justiﬁcation for a speciﬁc study
and of the costs of the study ﬁnancially and in terms of
risks and inconvenience to the population, needs to be in
terms of an appreciation of the knowledge needs for effec-
tive change management. This includes systematic knowl-
edge about the likely response of the health system when
ﬁndings of research are applied at scale so that policy
inferences can be drawn.
Ensure representative partnerships and convene a
deliberative process
We have outlined how health systems in complex and
dynamic contexts involve many actors, in both the formal
and informal sectors. We argue that it is important to
understand this plurality and attempt to ensure representa-
tion of different stakeholders in discussion about the fram-
ing and ethics of research and of proposed interventions.
In the ﬁrst instance, this involves dialogue and forms of
partnership with state policy-makers and potentially also
with relevant bureaucrats or senior managers in the health
system. However, consultation needs to extend beyond
government actors to extent to civil society actors and
beyond.
With respect to the views of the less powerful, one way
to ensure that the points of view of local people are con-
sidered is to establish some form of community engage-
ment as a part of health systems research, as has been
suggested for clinical research. This is not a simple pro-
cess. London’s41 comments on the dangers of assuming
communities are homogeneous, or neglecting the agency
of marginalised people with respect to seeking health,
remain very pertinent. Health system research involving
the implementation of health systems change at scale has
the potential to provide major beneﬁts to a community or
population. However, this kind of research, depending on
the nature of the change, can also entail risks, especially to
the poor and relatively powerless. They are vulnerable to
potential unintended consequences of a change process,
which could, for example, reduce access to services or
impair their quality. The community affected by such
change might have a different perception of these risks or
the consequences compared to the researchers. In a similar
vein, it is important to appreciate how large scale health
system change inevitably intersects with diverse social and
political aspirations and understandings of what constitutes
desirable change for the public good and how to achieve
this. This involves an understanding of broader societal
views of harm, and not just harm to individuals in medical
interactions. The views of those who negotiate a health
system and make do in the face of constraints to achieving
good health are crucial.
It is also difﬁcult to ensure that all those potentially
affected are fully informed of all possible beneﬁcial and
deleterious outcomes of an intervention. In each case, it is
important to determine the processes that constitute con-
sent to undertake an intervention. It is also important to
deﬁne the responsibilities of the researcher to monitor pos-
sible negative outcomes, especially for the poor and pow-
erless and ensure that action is taken to mitigate these
harms. We suggest that it is important for researchers to
convene deliberative processes that involve a range of
stakeholders prior to the initiation of research and at key
points in the research timetable.
Accept and address uncertainty
Even a well organised ethical review cannot adequately
ensure that unnecessary suffering is avoided, especially in
complex and rapidly changing contexts. It is important to
monitor for potentially deleterious unintended outcomes
and arrangements should be made to modify implementa-
tion of the research on the basis of ﬁndings. This will
involve a review of design and the potential ethical impact
at regular intervals. This requires the researchers to build
an iterative mechanism into the research process for care-
ful monitoring of outcomes and identifying consequences
and risks. This iterative review process should occur at
regular intervals in the timeframe of the research and the
researchers should decide carefully what information
should be brought to the table for such review. We recog-
nise that ongoing monitoring of outcomes and risks would
be burdensome if instituted for all HSPR. Consideration
could be given to specifying for review boards the kinds
of research or the research contexts where this would seem
particularly necessary, such as when an intervention is pro-
posed that is assessed as carrying a signiﬁcant risk of
potential unintended consequences.
Consider and address the timeframe of research
Timescale in an important consideration for HSR. If the
study concerns the implementation of major changes, it is
likely to take a considerable amount of time and raises
additional ethical considerations.42 These include important
questions about the measures to be taken to sustain any
interventions or to inform the community if interventions
are to be time limited. In such instances, further dialogue
is required regarding what disengagement would mean.
41 London, op.cit. note 11.
42 A.A. Hyder et al. Exploring the Ethics of Long-Term Research Engage-
ment with Communities in Low- and Middle-Income Countries. Public
Health Ethics. 2012.5:252-262
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CONCLUSION
We have discussed the ethical challenges faced by
researchers in complex and dynamic contexts where they
are working closely with policy-makers to provide evi-
dence for rapid health systems change at scale. We suggest
that longitudinal review should be considered at key points
in the HPSR project timeline as opposed to the traditional
one off review prior to the inception of research. Guideli-
nes could be developed to identify kinds of HSPR where
iterative monitoring would be particularly necessary. We
also maintain that a component of ethics review should
involve the convening of a deliberative process involving
participation by several key stakeholders and pay attention
to achieving adequate representation. Such a process could
encourage iterative learning and require adaptation on the
part of researchers. In contexts where social accountability
mechanisms have been established in the health system,
these could be engaged alongside civil society organisa-
tions. We contend that convening deliberative platforms at
key intervals in the research timeline is important in com-
plex contexts. However, reﬂexivity and critical reﬂection
on the part of researchers is also necessary in approaching
such ‘partnership’ with stakeholders in HPSR, and should
be underpinned by a commitment to social accountability.
As researchers and the institutes that employ them con-
tinue to develop their role as important contributors to the
management of health system innovation and change in a
complex and dynamic context, they will need to establish
mechanisms to ensure they work in a competent and ethi-
cal manner. Our aim is to stimulate debate about the pro-
cesses of review and reﬂection that could contribute to
achieving this purpose.
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